The FDA has accepted EnteroMedics' premarket approval application for its Maestro Rechargeable System's VBLOC neurostimulation implant. The device, which delivers electrical pulses to stimulate the vagus nerve, is intended to help treat patients with obesity.
EnteroMedics' application for obesity device accepted by FDA
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan